Transcranial magnetic stimulation (TMS) intervention for drug addiction

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024454

Enrollment

Unknown

Registered

2019-07-12

Start date

2019-07-20

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction

Interventions

Group 1:TMS treatment

Group 2:Pseudo stimulus

Health control group:None

Eligibility

Sex/Gender

Male

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Healthy; (2) Aged 18-45 years; (3) Meet the DSM-5 standard of methamphetamine dependence; (4) No contraindication to TMS: (5) Educational level above primary school; (6) Consent to attend this study.

Exclusion criteria

Exclusion criteria: (1) Have contraindications to TMS ,such as head trauma, epilepsy or the history of epilepsy, metal implant etc.; (2) Psychiatric illnesses; (3) Physical ailments; (4) Intellectual impairment (IQ<90).

Design outcomes

Primary

Measure	Time frame
physiological index (Such as blood, saliva, etc.);EEG signal;near-infrared index (Such as oxyhemoglobin, deoxyhemoglobin, etc. );Cognitive Performance;clinical outcomes;	—

Secondary

Measure	Time frame
Neuropsychological index (Such as depression, anxiety, craving, sleep, etc.);	—

Countries

China

Contacts

Public ContactJunhao Huang

GuangZhou Sport University

junhaohuang2006@hotmail.com+86 020-38025087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026